NCHC

National Coalition On Health Care

  • About Us
    • Members and Supporters
    • Board of Directors
    • Staff
    • Annual Reports
  • Policy
    • COVID-19 Response
    • Make Prescription Drugs More Affordable
    • Eliminate Surprise Medical Billing
    • Make Health Care Affordable and Accessible
    • Promote a High-Value Health Care System that Supports Vulnerable Populations
  • Blog
  • Events
  • Newsroom
    • Press Releases
    • NCHC In The News
    • Policy Correspondence
    • Fact Sheets & Issue Briefs
  • Get Involved
    • Become a Member
    • Become a Funder
    • Career Opportunities & Internships
  • Contact Us

AARP Brief Examines Threat to Biosimilar Drug Competition

September 26, 2014 By Larry McNeely

Tweet
Share

In 2010, as part of the federal health care law, Congress established a new pathway for the FDA to approve generic versions of biologic drugs, called biosimilars. Due to the rising cost burden generated by high-priced biologic drugs, biosimilars are a critical source of competition to protect the sustainability of our health system. Unfortunately, in state capitols around the country, efforts are underway to lessen the potential of biosimilars to bring life-saving medicines to more patients at an affordable price.

The AARP Public Policy Institute shines a light on this threat to health care affordability with their new brief A Sense of Déjà Vu: The Debate Surrounding State Biosimilar Substitution Laws. 

Filed Under: Blog

Mission

To bring together key stakeholders in order to achieve an affordable, high-value health care system for patients and consumers, for employers and other payers, and for taxpayers.

Signup for NCHC Newsletter

NCHC Recent Policy Correspondence

  • NCHC STATEMENT ON BICAMERAL AND BIPARTISAN SURPRISE BILLING LEGISLATION, “NO SURPRISES ACT,”
  • NCHC STATEMENT ON PART D REBATE SAFE HARBOR REPEAL AND “MOST FAVORED NATION” DEMONSTRATION
  • NCHC Statement On The Trump Administration’s “Most-Favored-Nation” Drug Pricing Executive Order
  • NCHC Statement on the Trump Administration’s Executive Orders
  • NCHC Statement on the Pricing of Remdesivir
...More Policy Correspondence

National Coalition on Health Care

About Us

The National Coalition on Health Care (NCHC) was formed more than two decades ago to help achieve comprehensive health system change and is currently led by John Rother. We aim to be a leader in promoting a healthy population and a more effective, efficient and responsive health system that provides quality care for all. NCHC is a nonpartisan, nonprofit organization of organizations. Our growing Coalition represents more than 80 participating organizations, including medical societies, businesses, unions, health care providers, faith-based associations, pension and health funds, insurers, and groups representing consumers, patients, women, … Read More...

PRESIDENT

John Rother

Interim CEO

Shawn Martin

CHAIRMAN

Jack Lewin
Principal and Founder
Lewin and Associates, LLC

MISSION

To bring together key stakeholders in order to achieve an affordable, high-value health care system for patients and consumers, for employers and other payers, and for taxpayers.

CONTACT US

900 16th Street NW, Suite 400
Washington, DC 20006
contactus@nchc.org

Connect With NCHC

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Recent News & Posts

  • Update on Most Favored Nation Rule Litigation
  • NCHC 2020 Year In Review
  • NCHC Letter to President-Elect Biden’s Transition Team
  • NCHC STATEMENT ON BICAMERAL AND BIPARTISAN SURPRISE BILLING LEGISLATION, “NO SURPRISES ACT,”
  • The Impact of COVID-19 on Communities of Color

Recent Tweets

Tweets by NC_HC

Copyright © 2021 · Outreach Pro Theme on Genesis Framework · WordPress · Log in